388 related articles for article (PubMed ID: 33680986)
21.
Shang X; Bai H; Fan L; Zhang X; Zhao X; Liu Z
Front Cell Infect Microbiol; 2024; 14():1387414. PubMed ID: 38751998
[TBL] [Abstract][Full Text] [Related]
22. Lacticaseibacillus rhamnosus Lcr35 Stimulates Epithelial Vaginal Defenses upon Gardnerella vaginalis Infection.
Miquel S; Verlaguet J; Garcin S; Bertran T; Evrard B; Forestier C; Vareille-Delarbre M
Infect Immun; 2022 Sep; 90(9):e0030922. PubMed ID: 36000874
[TBL] [Abstract][Full Text] [Related]
23. Gemini Cationic Amphiphiles Control Biofilm Formation by Bacterial Vaginosis Pathogens.
Algburi A; Zhang Y; Weeks R; Comito N; Zehm S; Pinto J; Uhrich KE; Chikindas ML
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893789
[TBL] [Abstract][Full Text] [Related]
24. Growth Forms of
Jung H; Ehlers MM; Peters RPH; Lombaard H; Redelinghuys MJ; Bezuidenhoudt JE; Kock MM
Front Cell Infect Microbiol; 2020; 10():71. PubMed ID: 32257961
[TBL] [Abstract][Full Text] [Related]
25. The Natural Antimicrobial Subtilosin A Synergizes with Lauramide Arginine Ethyl Ester (LAE), ε-Poly-L-lysine (Polylysine), Clindamycin Phosphate and Metronidazole, Against the Vaginal Pathogen Gardnerella vaginalis.
Cavera VL; Volski A; Chikindas ML
Probiotics Antimicrob Proteins; 2015 Jun; 7(2):164-71. PubMed ID: 25588687
[TBL] [Abstract][Full Text] [Related]
26. The Acid-Dependent and Independent Effects of Lactobacillus acidophilus CL1285, Lacticaseibacillus casei LBC80R, and Lacticaseibacillus rhamnosus CLR2 on Clostridioides difficile R20291.
Gunaratnam S; Diarra C; Paquette PD; Ship N; Millette M; Lacroix M
Probiotics Antimicrob Proteins; 2021 Aug; 13(4):949-956. PubMed ID: 33492661
[TBL] [Abstract][Full Text] [Related]
27. Probiotic lactobacilli inhibit early stages of Candida albicans biofilm development by reducing their growth, cell adhesion, and filamentation.
Matsubara VH; Wang Y; Bandara HMHN; Mayer MPA; Samaranayake LP
Appl Microbiol Biotechnol; 2016 Jul; 100(14):6415-6426. PubMed ID: 27087525
[TBL] [Abstract][Full Text] [Related]
28. Taxonomic and strain-specific identification of the probiotic strain Lactobacillus rhamnosus 35 within the Lactobacillus casei group.
Coudeyras S; Marchandin H; Fajon C; Forestier C
Appl Environ Microbiol; 2008 May; 74(9):2679-89. PubMed ID: 18326671
[TBL] [Abstract][Full Text] [Related]
29. Preclinical Data on the
Landlinger C; Oberbauer V; Podpera Tisakova L; Schwebs T; Berdaguer R; Van Simaey L; Vaneechoutte M; Corsini L
Antimicrob Agents Chemother; 2022 May; 66(5):e0231921. PubMed ID: 35416708
[TBL] [Abstract][Full Text] [Related]
30. Gardnerella Vaginalis Dominates Multi-Species Biofilms in both Pre-Conditioned and Competitive In Vitro Biofilm Formation Models.
Rosca AS; Castro J; França Â; Vaneechoutte M; Cerca N
Microb Ecol; 2022 Nov; 84(4):1278-1287. PubMed ID: 34741647
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effect of Lactobacillus gasseri CCFM1201 on Gardnerella vaginalis in mice with bacterial vaginosis.
Zhang Q; Cheng Q; Cui S; Zhao J; Chen W; Zhang H
Arch Microbiol; 2022 May; 204(6):315. PubMed ID: 35546374
[TBL] [Abstract][Full Text] [Related]
32. Using an in-vitro biofilm model to assess the virulence potential of bacterial vaginosis or non-bacterial vaginosis Gardnerella vaginalis isolates.
Castro J; Alves P; Sousa C; Cereija T; França Â; Jefferson KK; Cerca N
Sci Rep; 2015 Jun; 5():11640. PubMed ID: 26113465
[TBL] [Abstract][Full Text] [Related]
33. Lysozyme as a cotreatment during antibiotics use against vaginal infections: An in vitro study on Gardnerella vaginalis biofilm models.
Thellin O; Zorzi W; Zorzi D; Delvenne P; Heinen E; ElMoualij B; Quatresooz P
Int Microbiol; 2016 Jun; 19(2):101-107. PubMed ID: 27845497
[TBL] [Abstract][Full Text] [Related]
34. Interactions between Lactobacillus rhamnosus GG and oral micro-organisms in an in vitro biofilm model.
Jiang Q; Stamatova I; Kainulainen V; Korpela R; Meurman JH
BMC Microbiol; 2016 Jul; 16(1):149. PubMed ID: 27405227
[TBL] [Abstract][Full Text] [Related]
35. Comparative genomic and functional analysis of Lactobacillus casei and Lactobacillus rhamnosus strains marketed as probiotics.
Douillard FP; Ribbera A; Järvinen HM; Kant R; Pietilä TE; Randazzo C; Paulin L; Laine PK; Caggia C; von Ossowski I; Reunanen J; Satokari R; Salminen S; Palva A; de Vos WM
Appl Environ Microbiol; 2013 Mar; 79(6):1923-33. PubMed ID: 23315726
[TBL] [Abstract][Full Text] [Related]
36. Disruption of urogenital biofilms by lactobacilli.
McMillan A; Dell M; Zellar MP; Cribby S; Martz S; Hong E; Fu J; Abbas A; Dang T; Miller W; Reid G
Colloids Surf B Biointerfaces; 2011 Aug; 86(1):58-64. PubMed ID: 21497071
[TBL] [Abstract][Full Text] [Related]
37. Probiotic Lactobacillus sp. inhibit growth, biofilm formation and gene expression of caries-inducing Streptococcus mutans.
Wasfi R; Abd El-Rahman OA; Zafer MM; Ashour HM
J Cell Mol Med; 2018 Mar; 22(3):1972-1983. PubMed ID: 29316223
[TBL] [Abstract][Full Text] [Related]
38. Lactobacillus crispatus inhibits growth of Gardnerella vaginalis and Neisseria gonorrhoeae on a porcine vaginal mucosa model.
Breshears LM; Edwards VL; Ravel J; Peterson ML
BMC Microbiol; 2015 Dec; 15():276. PubMed ID: 26652855
[TBL] [Abstract][Full Text] [Related]
39. Effect of Oral Probiotic
Yang S; Reid G; Challis JRG; Gloor GB; Asztalos E; Money D; Seney S; Bocking AD
Nutrients; 2020 Jan; 12(2):. PubMed ID: 32019222
[TBL] [Abstract][Full Text] [Related]
40. Exploring of probiotic potential vaginal lactobacillus isolates from healthy women against Gardnerella vaginalis and Caenorhabditis elegans model testing.
Li Y; Jiang Y; Lessing DJ; Chu W
J Appl Microbiol; 2022 Sep; 133(3):1392-1401. PubMed ID: 35633296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]